SeaStar Medical Holding (ICU) Interest Expenses (2022 - 2026)
SeaStar Medical Holding's (ICU) quarterly Interest Expenses came in at $6000.0 in Q1 2026, down 45.45% YoY from $11000.0 in Q1 2025, and down 99.98% on a QoQ basis from $32.0 million in Q4 2025.
SeaStar Medical Holding (ICU) Interest Expenses (2022 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 5 years of Interest Expenses data on file, last reported at $6000.0 in Q1 2026.
- Quarterly Interest Expenses fell 45.45% year-over-year to $6000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $56000.0 (down 85.82% YoY) and the FY2025 annual result came in at $32.0 million, up 12.19% from the prior year.
- Interest Expenses eased to $6000.0 in Q1 2026, from $32.0 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $32.0 million in Q4 2025 to a low of $6000.0 in Q4 2022.
- A 5-year average of $2.1 million and a median of $156000.0 in 2022 frame the typical range for Interest Expenses.
- The widest YoY moves for Interest Expenses: up 106530.0% in 2025, down 92.31% in 2025.
- Tracing ICU's Interest Expenses over 5 years: stood at $6000.0 in 2022, then surged by 3966.67% to $244000.0 in 2023, then plunged by 87.7% to $30000.0 in 2024, then jumped by 106530.0% to $32.0 million in 2025, then slumped by 99.98% to $6000.0 in 2026.
- The last three Interest Expenses figures came in at $6000.0 (Q1 2026), $32.0 million (Q4 2025), and $9000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | SeaStar Medical Holding | 13.68 Mn | 6.68 Mn | 561,000.00 | 8,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8,000.00 |
| Jun 30, 2026 | 8,000.00 |
| Mar 31, 2026 | 6,000.00 |
| Mar 31, 2026 | 6,000.00 |
| Dec 31, 2025 | 31.99 Mn |
| Dec 31, 2025 | 31.99 Mn |
| Jun 30, 2025 | 9,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Dec 31, 2024 | 30,000.00 |
| Dec 31, 2024 | 30,000.00 |
| Sep 30, 2024 | 272,000.00 |
| Sep 30, 2024 | 272,000.00 |
| Jun 30, 2024 | 82,000.00 |
| Jun 30, 2024 | 82,000.00 |
| Mar 31, 2024 | 143,000.00 |
| Mar 31, 2024 | 143,000.00 |
| Dec 31, 2023 | 244,000.00 |
| Dec 31, 2023 | 244,000.00 |